The University of Texas at Austin

The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alleviates depression-like behavior and normalizes epigenetic changes in the hippocampus during ethanol withdrawal

Citation:

Chen WY, Zhang H, Gatta E, Glover EJ, Pandey SC, and Lasek AW. “The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alleviates depression-like behavior and normalizes epigenetic changes in the hippocampus during ethanol withdrawal.” Alcohol, 78, Pp. 79-87. Publisher's Version

Publication List by Year

In Press (5)
2024 (5)
2023 (23)
2022 (25)
2021 (36)
2020 (55)
2019 (77)
2018 (47)
2017 (50)
2016 (48)